Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | HMY | CGNX |
|---|---|---|
| Price | $17.30 | $64.37 |
| Change today | ▼ 0.46% | ▼ 0.92% |
| Market cap | $10.83B | $10.83B |
| Return, 3 months | +12.3% | +0.4% |
| Return, year to date | -11.4% | +79.7% |
| Return, 1 year | -4.8% | +38.2% |
| P/E (TTM) | 6.2 | 61.9 |
| P/B | 2.4 | 6.6 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 2.43% | 0.52% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 38 | 59 |
| 30-day volatility | 50.8% | 40.6% |
| Max drawdown, 1 year | -48.8% | -27.9% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
